19 July 2024

Kinovo plc

("Kinovo" or the "Company")

Exercise of Options and Total Voting Rights

Kinovo PLC (AIM: KINO), the specialist property services group that delivers compliance and sustainability solutions, announces that it has received notice by a former employee of the Company to exercise options over 100,000 new ordinary shares of 10p each ("New Ordinary Shares").

Admission and Total Voting Rights

Application has been made for the 100,000 New Ordinary Shares to be admitted to trading on AIM which is expected to occur on 22 July 2024 ("Admission"). The 100,000 New Ordinary Shares will rank pari passu with the Company's existing shares.

Following Admission, the issued share capital of the Company will be 63,018,214 Ordinary Shares with one voting right each. The Company does not hold any shares in treasury.

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries

Kinovo plc
Sangita Shah, Chair David Bullen, Chief Executive Officer	+44 (0)20 7796 4133 (via Hudson Sandler)
Canaccord Genuity Limited (Nominated Adviser and Sole Broker)	+44 (0)20 7523 8000
Adam James Andrew Potts Harry Rees
Hudson Sandler (Financial PR)	+44 (0)20 7796 4133
Dan de Belder Harry Griffiths

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END